Impact
Collaboration, commercialisation as well as high-impact publications allow to accelerate translation of breakthrough therapies and diagnostics into clinical practice.
Principle Investigators within CREATE Health have founded several spin-off companies which are already helping patients all around the world. Beside that, tens of research articles with ground-breaking discoveries have been published in renowned high-impact journals influencing and deepening the knowledge in the cancer field. Two EU co-funded CanFaster programs brought 32 international talents to the region and started their scientific career in academia, industry and beyond.